Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll mTOR signaling in cancer cell motility and tumor metastasis Zhou H; Huang SCrit Rev Eukaryot Gene Expr 2010[]; 20 (1): 1-16Tumor cell migration is a key step in the formation of cancer metastasis. The mammalian target of rapamycin (mTOR), a highly conserved and ubiquitously expressed serinethreonine kinase, has been intensely studied for over a decade as a central regulator of cell growth, proliferation, differentiation, and survival. Recent data have shown that mTOR also plays a critical role in the regulation of tumor cell motility and cancer metastasis. Here, we briefly review recent advances regarding mTOR signaling in tumor cell motility. We also discuss recent findings about the mechanism by which rapamycin, a specific inhibitor of mTOR, inhibits cell motility in vitro and metastasis in vivo.|Animals[MESH]|Cause of Death[MESH]|Cell Line[MESH]|Cell Movement/drug effects/*physiology[MESH]|Humans[MESH]|Insulin-Like Growth Factor I/physiology[MESH]|Intracellular Signaling Peptides and Proteins/*physiology[MESH]|Ligands[MESH]|Neoplasm Metastasis/*pathology[MESH]|Neoplasms/mortality/*pathology/*physiopathology[MESH]|Protein Serine-Threonine Kinases/*physiology[MESH]|Receptor, IGF Type 1/physiology[MESH]|Signal Transduction/drug effects/*physiology[MESH]|Sirolimus/pharmacology[MESH]|TOR Serine-Threonine Kinases[MESH] |